This study explores Mozafari-type liposomes as a novel, cost-effective delivery system for hyperstabilised FGF2-STAB®, addressing challenges in protein instability and controlled release. Furthermore, this project aims to integrate dual-fluorescent labelling to characterise protein-liposome interactions in vitro and ex vivo, offering new insights into regenerative medicine. Collaborations with Enantis, Ltd. and the University of Lyon enhance the study’s impact, supporting clinical translation and commercialisation prospects.

CEITEC VUT-J-25-8871

Czech

Kadlecová Zuzana, Ing. - principal person responsible
Vojtová Lucy, doc. Ing., Ph.D. - fellow researcher

Advanced Biomaterials
- responsible department (3.3.2025 - not assigned)
Central European Institute of Technology BUT
- responsible department (31.1.2025 - 3.3.2025)
Advanced Biomaterials
- beneficiary (1.1.2025 - 31.12.2025)

Responsibility: Kadlecová Zuzana, Ing.